Table 2.
Distribution of lung involvement.
Age | Gender | 2020 |
2021 |
||||
---|---|---|---|---|---|---|---|
None (n) |
Unilateral (n) |
Bilateral (n) |
None (n) |
Unilateral (n) |
Bilateral (n) |
||
<20 | Male | - | - | - | 1 | - | - |
Female | 1 | - | - | 1 | - | - | |
20–29 | Male | - | - | - | - | - | 1 |
Female | 2 | - | - | 1 | - | - | |
30–39 | Male | 3 | - | 1 | - | - | 4 |
Female | 4 | - | - | 2 | - | 2 | |
40–49 | Male | - | - | 7 | 3 | - | 8 |
Female | 4 | - | 1 | 1 | - | 2 | |
50–59 | Male | 1 | - | 6 | - | - | 3 |
Female | - | 1 | - | 1 | - | 2 | |
60–69 | Male | 1 | - | 8 | 1 | 2 | 6 |
Female | 2 | - | 3 | - | - | 1 | |
70–79 | Male | 1 | - | 2 | - | - | 2 |
Female | - | 1 | - | - | - | 4 | |
80–89 |
Male | - | - | 1 | - | - | 1 |
Female | - | - | - | - | - | 1 | |
Total | 19 | 2 | 29 | 11 | 2 | 37 |